Patient Oriented Discharge Summary Impact Study

NCT ID: NCT02673892

Last Updated: 2019-07-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

581 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-02-29

Study Completion Date

2018-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Improving the patient experience has become a major focus of quality improvement efforts in Ontario and in health systems worldwide. However, our existing knowledge base is relatively under-developed, particularly in how patients experience care as they transition from one care setting to another and the relationship between patient experience and clinical outcomes. The Patient Oriented Discharge Summary (PODS) is a discharge instruction tool created by patients, caregivers, health-care providers and design experts. It provides a written template for providers to engage patients and caregivers when reviewing important instructions on medications, activity and diet restrictions, follow-up appointments and worrisome symptoms warranting emergency care following admission to hospital. The PODS also uses plain and simple wording, large fonts, pictograms, and includes white space for patients to take notes and provides the option for translation of major headings into the most common spoken languages. The PODS impact study will study the impact of using the PODS versus usual discharge instructions on patient experience and health outcomes in a provincial-wide randomized study across acute care and rehabilitation hospitals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Full Title: The impact of a patient-centered discharge summary (PODS) on patient experience and health outcomes following discharge: A multicenter randomized controlled trial.

Short Title: PODS Impact Study

Primary Objective: To evaluate the impact of a patient-centered discharge instruction tool on patient experience following hospital discharge.

Primary Outcome Measure: Patient experience within 72 hours following discharge from hospital. Count of negative responses (i.e., "No", or "Not at all" or "Partly") to 6 prespecified questions on patient experience of transition of care answered 72 hours following discharge from hospital, with the first 5 questions from the CIHI Patient Experiences Survey - In-Patient Care (CPES-IC). Groups will be compared using a rate ratio (ratio of negative binomial rates).

Secondary Objectives: 1) Evaluate the impact of a patient-centered discharge instruction tool on health outcomes following hospital discharge. 2) Identify the level of patient and system engagement needed when providing discharge instructions and patient-specific characteristics that might impact the use and effectiveness of discharge instructions.

Secondary Outcome Measures: Self-reported adherence to medications, diet and activity restrictions, and scheduled visits with primary care physician and/or specialist at 30 days following discharge, and a composite of unscheduled visits to primary care physician, emergency room, readmission to hospital or death at 30 days and 3 months following discharge. Proportion of patients who responded "Yes", or "Quite a Bit" or "Completely", to 4 out of the 6 prespecified questions on patient experience of transitions of care, 72 hours following discharge from hospital as a measure of patient experience of their transition of care (original primary outcome, re-specified as secondary outcome based on DMC recommendation).

Study Design: The study will use a mixed methods approach with a randomized controlled trial (RCT) and qualitative study.

Inclusion Criteria: All patients (\>=18 years) admitted to inpatient units at University Health Network (UHN) (and other participating hospitals in Ontario) with a primary diagnosis of chronic obstructive pulmonary disease, pneumonia, stroke, congestive heart failure, post hip and knee replacement will be recruited for randomization to receive the PODS versus standard of discharge care. These diseases were chosen to align with the Ministry of Health and Long Term Care (MOHLTC) quality based procedures.

Exclusion Criteria: Patients who are being discharged to another facility rather than home, who have a prognosis of less than 3 months, who do not have a telephone for post-discharge follow-up or with cognitive impairment or significant language barrier for whom a family member or professional interpreter is not available will be excluded from the study.

Intervention: The patient-oriented discharge summary (PODS) is a discharge instruction tool co-created with patients which provides a written template for providers to engage patients and caregivers when reviewing discharge instructions on medications, activity and diet restrictions, follow-up appointments or outstanding investigations and worrisome symptoms warranting emergency care (Appendix A). The PODS also uses plain and simple wording, large fonts, pictograms, and includes white space for patients to take notes and provides the option for translation of major headings into the most common spoken languages. As this will be a pragmatic design, we may make modifications to the process involved in completing the PODS, such as using pre-filled disease-specific information, if system processes and providers involved deem it more usable and feasible.

Sample Size: We estimate that we will require at minimum 199 and at maximum 388 patients in each study arm if we want to detect a 10% minimum improvement in patient experience scores. Currently, we have study centers that would like to participate in Toronto, Ottawa and Thunder Bay.

Accrual Period: Enrollment for this study will begin once ethics approval is obtained and continue until 776 patients have been enrolled (in total across all participating sites).

Study Duration: The study is expected to run between December 1, 2015 and March 31, 2018 (approximately 3 years) following research ethics board (REB) approval. This will allow for a year of study enrollment across participating sites until sample size is achieved as well as 3 months of follow-up for primary and secondary endpoints and a year for data analysis and manuscript preparation.

Data Monitoring Committee (DMC): A DMC was established on May 4, 2018, due to challenges in recruitment and widespread implementation of the intervention across multiple hospitals in Ontario resulting in a change in the standard of discharge care in the trial's setting. In view of the challenges in recruiting future patients, resource constraints, and statistical considerations, the DMC recommended that recruitment be stopped prematurely and that the analytical approach for the primary outcome be changed, analyzing the data as count data rather than dichotomized data. Study recruitment was stopped at the end of August 2018, after a total of 526 participants had been randomized, with final follow up of participants in December 2018 (see the Document Section for full details).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congestive Heart Failure Chronic Obstructive Pulmonary Disease Pneumonia Hip Fracture Total Hip Replacement Total Knee Replacement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PODS intervention

The PODS intervention is administered during the discharge process which includes discharge teaching. In the acute settings, discharge teaching is provided by a nurse navigator, resident physician, or other members of the care team. In the rehabilitation setting, discharge teaching is provided by a multi-disciplinary team. PODS is used as a useful add-on to the usual discharge teaching process. The PODS form used during the study will be a fillable pdf. Members of the healthcare team will fill it out electronically, then print it out and give the paper to the patient. After the discharge teaching is finished, patients take the completed PODS home with them as a post-discharge reference and guide.

Group Type EXPERIMENTAL

Patient Oriented Discharge Summary

Intervention Type OTHER

The PODS provides a written template for providers to engage patients and caregivers when reviewing important discharge instructions on medications, activity and diet restrictions, follow-up appointments and worrisome symptoms warranting emergency care. The PODS also uses plain and simple wording, large fonts, pictograms, and includes white space for patients to take notes and provides the option for translation of major headings into the most common spoken languages. As this will be a pragmatic design, we may make modifications to the process involved in completing the PODS, such as using pre-filled disease-specific information, if system processes and providers involved deem it more usable and feasible.

Usual Care

Patients randomized to this arm will receive usual discharge care. At UHN, this involves receiving a discharge summary with information pertaining to hospital course including investigations performed and medications used, as well as follow-up care suggested. It is intended to be, unlike PODS, a document for the primary care physician seeing the patient after discharge to refer to. As to discharge instructions provided for the patient, there is no standard procedure and sometimes follow-up instructions are included for the patient. Patient education may or may not be provided to the patient verbally by their nurse, resident, physician, or pharmacist. Moreover, follow-up with the primary care physician may be set up prior to or following discharge with the nurse navigator.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient Oriented Discharge Summary

The PODS provides a written template for providers to engage patients and caregivers when reviewing important discharge instructions on medications, activity and diet restrictions, follow-up appointments and worrisome symptoms warranting emergency care. The PODS also uses plain and simple wording, large fonts, pictograms, and includes white space for patients to take notes and provides the option for translation of major headings into the most common spoken languages. As this will be a pragmatic design, we may make modifications to the process involved in completing the PODS, such as using pre-filled disease-specific information, if system processes and providers involved deem it more usable and feasible.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or over
* Able and willing to provide informed consent or have a substitute decision maker that can provide consent and agree to answer follow up as the patient's caregiver
* Admitted to hospital with either congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), Stroke, Pneumonia, Hip Fracture, Knee Replacement or Hip Replacement
* Being discharged home or to a retirement home
* Have a Telephone for post-discharge follow-up

Exclusion Criteria

* Patients who have already received the PODS in the past
* Being discharged to nursing home, long-term care facility, rehabilitation or other hospital.
* Unable to communicate due to cognitive impairment or language barrier with no caregiver or interpreter available
* Palliative patient with life expectancy \<= 3 months
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baycrest

OTHER

Sponsor Role collaborator

Bruyère Health Research Institute.

OTHER

Sponsor Role collaborator

Thunder Bay Regional Health Sciences Centre

OTHER

Sponsor Role collaborator

Mount Sinai Hospital, Canada

OTHER

Sponsor Role collaborator

University Health Network, Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karen Okrainec, MD

Role: PRINCIPAL_INVESTIGATOR

UHN

Howard B Abrams, MD

Role: PRINCIPAL_INVESTIGATOR

UHN

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Toronto General Hospital

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-9735-AE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of a Mobility Program
NCT02674503 COMPLETED NA
Navigator Program for Homeless Adults
NCT04961762 ACTIVE_NOT_RECRUITING NA
Study Human Digital Support Transitional Care
NCT06354166 NOT_YET_RECRUITING NA